Tritonix.ai

News / Taiwan / economic_daily

Ever Supreme Bio Tech Reports Strong August Revenue Growth as CAR001 Clinical Trials Advance

Health Technology · Biotechnology · economic_daily · 2026-09-01

6712

Ever Supreme Bio Tech announced an 11% monthly revenue increase for August, driven by steady demand for cell therapy services and CDMO operations while advancing its CAR001 cancer treatment.

What Happened

Revenue Performance: Ever Supreme Bio Tech reported August revenue of NT$109 million, marking a 21% year-over-year increase and an 11% month-over-month rise. Cumulative revenue for the first eight months of the year reached NT$669 million, reflecting a 17% growth compared to the same period last year.

Growth Drivers: The company attributed its strong financial results to the steady expansion of its cell storage, cell preparation services, and CDMO business. These core segments provide a stable financial foundation that supports the company's ongoing research and development initiatives.

Clinical Progress: The company's flagship CAR001 therapy has successfully completed Phase I trials and is currently in the Phase IIa stage of clinical development. This treatment utilizes AI-assisted design and mRNA non-viral electroporation technology to target advanced or refractory solid tumors.

Future Outlook: Looking ahead, Ever Supreme intends to leverage its CDMO and cell therapy services as a stable operational base while advancing its pipeline, including EXO001 and dEV001. The company remains focused on deepening its expertise in AI, mRNA, and exosome technologies to facilitate future international licensing and clinical expansion.

Read original

More in Health Technology

Yuhan Corp. Secures 131.1 Billion Won API Supply Deal with Global Pharma

Health Technology · yonhap_finance · 2026-09-01

Yuhan Corp. has signed a 131.1 billion won contract to supply active pharmaceutical ingredients to an undisclosed global pharmaceutical company through 2028.

000100

DB Asset Management Launches Active ETF Focused on Innovative Drug Developers

Health Technology · yonhap_finance · 2026-09-01

DB Asset Management has listed a new active ETF targeting promising South Korean companies specializing in innovative drug development and pipelines.

Eli Lilly Expands Biotech Portfolio via Merida Biosciences Acquisition

Health Technology · cnbc · 2026-08-31

Eli Lilly is deploying its obesity-driven cash reserves to acquire Merida Biosciences for $2.875 billion, while GE Vernova shares face pressure from SpaceX manufacturing rumors.

.SPX, LLY, GEV, HWM, @CL26V, @LCO26X, XLE, PEP, XLV, MDT, XLK, XLU

Latest in Taiwan

Taiwan Stocks Surge to Two-Month High as Foreign Investors Pivot to Active ETFs

Electronic Technology · economic_daily · 2026-09-01

Taiwan stocks jumped over 820 points to a two-month high, fueled by MediaTek's rally following a $3.5 billion investment from NVIDIA and strong foreign buying.

Skytech Launches Advanced Process Lab with TSMC Support

Electronic Technology · cnyes · 2026-09-01

Semiconductor equipment maker Skytech has inaugurated its new advanced process laboratory, with a rare appearance by a TSMC executive signaling stronger local supply chain collaboration.

2330, 6937

PlayNitride Targets Mass Production of Tandem Micro LED to Drive Commercial Scaling

Electronic Technology · cnyes · 2026-09-01

PlayNitride is advancing its tandem Micro LED architecture to reduce power consumption and accelerate commercial adoption in wearables and automotive displays.

6854

Nan Ya Plastics Hits Record High of NT$250 Amid AI-Driven Material Demand

Electronic Technology · economic_daily · 2026-09-01

Nan Ya Plastics shares reached a record high of NT$250 as the company reports strong July earnings and benefits from surging demand for AI-related materials.